PubRank

A Rein

Author PubWeight™ 145.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci U S A 1986 7.02
2 Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc Natl Acad Sci U S A 1988 6.44
3 Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol 1990 5.45
4 Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology 1985 4.65
5 Effects of local cell concentrations upon the growth of chick embryo cells in tissue culture. Exp Cell Res 1968 3.94
6 Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells. Virology 1982 3.86
7 Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol 1993 3.78
8 Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J Virol 1990 3.77
9 Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol 1994 3.54
10 RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A 2001 3.45
11 In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol 1999 3.34
12 The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J Virol 1993 3.29
13 Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc Natl Acad Sci U S A 1998 3.24
14 Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J Virol 2000 2.98
15 Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J Virol 1989 2.90
16 Different recombinant murine leukemia viruses use different cell surface receptors. Virology 1984 2.85
17 Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU. J Virol 1992 2.61
18 Phenotypic mixing between N- and B-tropic murine leukemia viruses: infectious particles with dual sensitivity to Fv-1 restriction. Cell 1976 2.34
19 Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure. J Virol 1984 2.32
20 HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc Natl Acad Sci U S A 1996 2.30
21 Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. J Virol 1998 2.18
22 Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J Virol 1998 2.14
23 Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci U S A 2001 2.07
24 The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J Virol 1999 2.04
25 Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology 1982 2.02
26 Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle. Cell 1977 1.95
27 Translational suppression in retroviral gene expression. Adv Virus Res 1992 1.93
28 Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule. J Virol 1979 1.90
29 Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J Virol 1996 1.83
30 Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J Virol 1996 1.69
31 Murine sarcoma virus pseudotypes acquire a determinant specifying N or B tropism from leukaemia virus during rescue. Nature 1975 1.68
32 Dual susceptibility of A 3T3 mouse cell line to infection by N- and B-tropic murine leukemia virus: apparent lack of expression of the FV-1 gene. Int J Cancer 1974 1.65
33 Inhibitors of glycosylation reverse retroviral interference. Virology 1982 1.64
34 Bipartite signal for read-through suppression in murine leukemia virus mRNA: an eight-nucleotide purine-rich sequence immediately downstream of the gag termination codon followed by an RNA pseudoknot. J Virol 1992 1.60
35 Donation of N- or B-tropic phenotype to NB-tropic murine leukemia virus during mixed infections. J Virol 1977 1.52
36 Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology 1985 1.49
37 Chromatographic analysis of the aminoacyl-tRNAs which are required for translation of codons at and around the ribosomal frameshift sites of HIV, HTLV-1, and BLV. Virology 1989 1.47
38 Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus. Proc Natl Acad Sci U S A 1990 1.45
39 Poorly expressed endogenous ecotropic provirus of DBA/2 mice encodes a mutant Pr65gag protein that is not myristylated. J Virol 1988 1.43
40 An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo. Proc Natl Acad Sci U S A 1991 1.35
41 Placement of tRNA primer on the primer-binding site requires pol gene expression in avian but not murine retroviruses. J Virol 1997 1.34
42 Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences. J Virol 1992 1.33
43 Suppression of UAA and UGA termination codons in mutant murine leukemia viruses. J Virol 1989 1.32
44 Characterization of the block in replication of nucleocapsid protein zinc finger mutants from moloney murine leukemia virus. J Virol 1999 1.32
45 Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA. J Virol 1989 1.28
46 Rescue and transmission of a replication-defective variant of moloney murine leukemia virus. J Virol 1979 1.25
47 Biological, chemical, and immunological studies of Rauscher ecotropic and mink cell focus-forming viruses from JLS-V9 cells. J Virol 1983 1.25
48 Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3. Mol Cell Biol 1985 1.20
49 The genomic RNA in Ty1 virus-like particles is dimeric. J Virol 2000 1.14
50 Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation. J Virol 1978 1.11
51 Species specificity of the low molecular weight nuclear RNA's. Biochim Biophys Acta 1969 1.08
52 Multiple regions of Harvey sarcoma virus RNA can dimerize in vitro. J Virol 1995 1.07
53 Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. Virology 2006 1.05
54 Mechanism of restriction of murine leukemia viruses varies between different strains of Fv-1n mice. Int J Cancer 1979 1.04
55 Replication-defective ecotropic murine leukemia viruses: Detection and quantitation of infectivity using helper-dependent XC plaque formation. J Virol 1978 1.03
56 Baboon endogenous virus genome: molecular cloning and structural characterization of nondefective viral genomes from DNA of a baboon cell strain. Proc Natl Acad Sci U S A 1981 1.00
57 Isolation of a replication-defective murine leukaemia virus from cultured AKR leukaemia cells. Nature 1979 0.98
58 Molecular properties of a gag- pol- env+ murine leukemia virus from cultured AKR lymphoma cells. J Virol 1982 0.95
59 Macromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses. J Virol 1980 0.95
60 Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells. J Immunol 1988 0.94
61 Balb/3T3 cells chronically infected with N-tropic murine leukemia virus continue to express Fv-1b restriction. Virology 1981 0.92
62 Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication. Proc Natl Acad Sci U S A 1995 0.91
63 Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cell lines. J Virol 1998 0.89
64 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration. Virology 1994 0.87
65 Simian virus 40 rapidly lowers cAMP levels in mouse cells. Biochem Biophys Res Commun 1973 0.86
66 On the survival of chick embryo cells at low concentrations in culture. Exp Cell Res 1971 0.86
67 The small molecular weight monodisperse nuclear RNA's in mitotic cells. Biochim Biophys Acta 1971 0.84
68 Therapeutic effect of Gag-nuclease fusion protein on retrovirus-infected cell cultures. J Virol 1996 0.83
69 A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay. Gene Ther 2012 0.81
70 Synthesis of the small molecular weight monodisperse nuclear RNA's in contact-inhibited cell cultures. J Cell Physiol 1972 0.81
71 Giant cystic hygroma associated with venous aneurysm. J Pediatr Surg 1992 0.80
72 Lack of functional Pit-1 and Pit-2 expression on hematopoietic stem cell lines. Acta Haematol 1998 0.79
73 Mitral valve prolapse and panic attacks. Isr J Med Sci 1982 0.79
74 Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting. Am J Manag Care 2001 0.78
75 Transfer of murine leukaemia and murine sarcoma virus genetic information by transfection with isolated metaphase chromosomes. J Gen Virol 1982 0.78
76 In situ hybridization: general infectivity assay for retroviruses. J Virol 1982 0.75
77 A rapid method for collecting and assaying gradient fractions for radioactive macromolecules. Biochem J 1974 0.75
78 Production of the cephalosporate C-2 by a Streptomyces lactamdurans mutant defective in cephamycin C biosynthesis. J Antibiot (Tokyo) 1984 0.75
79 Neonatal surgery casebook. Congenital aplasia of iliac veins. J Perinatol 1990 0.75
80 [Ornithine-vasopressin (POR-8) as vasoconstrictor agent in regional anesthesia. II]. Anaesthesist 1972 0.75
81 Benefits of an automated narcotic retrieval system. Nurs Manage 1993 0.75
82 Intravenous amrinone therapy: nursing implications. Dimens Crit Care Nurs 1990 0.75
83 Isolation and characterization of a unique C57BL B-tropic virus. Virology 1980 0.75
84 Comparison of technologies in medication administration. Nurs Econ 1992 0.75
85 Early calcification and obstruction of a mitral porcine bioprosthesis. Ann Thorac Surg 1980 0.75
86 Proximity effects in the growth of animal cells. Wistar Inst Symp Monogr 1967 0.75
87 [2 trials of measuring the flow of the intraorbital ophthalmic artery using pulsed Doppler]. J Fr Ophtalmol 1985 0.75
88 Advancement of physical process by mental activation: a prospective controlled study. J Rehabil Res Dev 2012 0.75
89 [Transesophageal echocardiography--recent developments]. Harefuah 1992 0.75
90 Effect of camptothecin on simian virus 40 DNA. Nature 1974 0.75